Standout Papers
Citation Impact
Citing Papers
Pazopanib, a Multikinase Angiogenesis Inhibitor, in Patients With Relapsed or Refractory Advanced Soft Tissue Sarcoma: A Phase II Study From the European Organisation for Research and Treatment of Cancer–Soft Tissue and Bone Sarcoma Group (EORTC Study 62043)
2009 Standout
First-in-Human Study Testing a New Radioenhancer Using Nanoparticles (NBTXR3) Activated by Radiation Therapy in Patients with Locally Advanced Soft Tissue Sarcomas
2016
Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data
1997 Standout
Basal ganglia role in behavior: importance of sensory gating and its relevance to psychiatry.
1984
Concentration of vascular endothelial growth factor in the tumour tissue as a prognostic factor of soft tissue sarcomas
2001
Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin
2004
Postoperative Nomogram for 12-Year Sarcoma-Specific Death
2002
Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size
2011 Standout
Palliative therapy of disseminated malignant melanoma: a systematic review of 41 randomised clinical trials
2003
Single‐institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting
2010 StandoutNobel
Hyperthermia in combined treatment of cancer
2002 Standout
The influence of anatomic location on outcome in patients with soft tissue sarcoma of the extremity
2003
Grading of soft tissue sarcomas: from histological to molecular assessment
2013
The treatment of high-grade soft tissue sarcomas with preoperative thermoradiotherapy
1999
Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities.
1996 Standout
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐up
1991 Standout
Effect of Aging on Cardiac Contractility in a Rat Model of Chronic Daunorubicin Cardiotoxicity
2002
Modified Staging System for Extremity Soft Tissue Sarcomas
1999
Serum levels of vascular endothelial growth factor and basic fibroblast growth factor in patients with soft-tissue sarcoma
1999
Heating the patient: a promising approach?
2002 Standout
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
The cardiovascular health study: Design and rationale
1991 Standout
Soft Tissue Sarcomas
2004
Molecular characterisation of soft tissue tumours: a gene expression study
2002 Standout
Nomograms in oncology: more than meets the eye
2015 Standout
Nanoparticle therapeutics: an emerging treatment modality for cancer
2008 Standout
Incidence of Sarcoma Histotypes and Molecular Subtypes in a Prospective Epidemiological Study with Central Pathology Review and Molecular Testing
2011 Standout
Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial
2002 Standout
Cremophor EL
2001 Standout
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
Risk Factors for Local Recurrence and Metastasis in Soft Tissue Sarcomas of the Extremity
2011
Nanocarriers as an emerging platform for cancer therapy
2007 Standout
Soft-Tissue Sarcomas in Adults
2005 Standout
Paclitaxel (TaxolTM) and docetaxel (TaxotereTM): Not simply two of a kind
1994
Evaluation of a Clinically Applicable Post-Surgical Classification System for Primary Retroperitoneal Soft-Tissue Sarcoma
2004
Neoadjuvant chemotherapy combined with regional hyperthermia (RHT) for locally advanced primary or recurrent high-risk adult soft-tissue sarcomas (STS) of adults
2001
Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978–2001: An analysis of 26,758 cases
2006 Standout
A systematic meta‐analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft‐tissue sarcoma
2008 Standout
Molecular mechanisms of cisplatin resistance
2011 Standout
Refinement of clinicopathologic staging for localized soft tissue sarcoma of the extremity: a study of 423 adults.
1992
A Postoperative Nomogram for Local Recurrence Risk in Extremity Soft Tissue Sarcomas After Limb-Sparing Surgery Without Adjuvant Radiation
2011
Validation and adaptation of a nomogram for predicting the survival of patients with extremity soft tissue sarcoma using a three‐grade system
2004
Alveolar rhabdomyosarcomas in conditional Pax3:Fkhr mice: cooperativity of Ink4a/ARF and Trp53 loss of function
2004 StandoutNobel
Polymer conjugates as anticancer nanomedicines
2006 Standout
Pathological prognostic factors in breast cancer
1999 Standout
A comparison of staging systems for localized extremity soft tissue sarcoma
2000
Prognostic factors for patients with localized soft‐tissue sarcoma treated with conservation surgery and radiation therapy
2003
Targeting apoptosis in cancer therapy
2020 Standout
CTLA-4 blockade increases antigen-specific CD8+ T cells in prevaccinated patients with melanoma: three cases
2011 StandoutNobel
Promises and challenges for the implementation of computational medical imaging (radiomics) in oncology
2017 Standout
Preoperative vs. postoperative radiotherapy in the treatment of soft tissue sarcomas: a matter of presentation
1998
Isolated Limb Perfusion with Tumor Necrosis Factor and Melphalan for Limb Salvage in 186 Patients with Locally Advanced Soft Tissue Extremity Sarcomas
1996
Prognostication in soft tissue sarcoma.A model with four risk factors
1988
Chemotherapy Is Associated With Improved Survival in Adult Patients With Primary Extremity Synovial Sarcoma
2007
Texture Analysis of Non–Contrast-Enhanced Computed Tomography for Assessing Angiogenesis and Survival of Soft Tissue Sarcoma
2015
Epirubicin
1993
Tumor delivery of macromolecular drugs based on the EPR effect
2010 Standout
Imaging Primary Mouse Sarcomas After Radiation Therapy Using Cathepsin-Activatable Fluorescent Imaging Agents
2013 StandoutNobel
Epirubicin
1993
Limb salvage in musculoskeletal oncology
2003
Intraoperative detection and removal of microscopic residual sarcoma using wide‐field imaging
2012 StandoutNobel
Microbial drug discovery: 80 years of progress
2009
Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity.
1998 Standout
Prognostic Factors Predictive of Survival and Local Recurrence for Extremity Soft Tissue Sarcoma
1994
The Ki-67 protein: From the known and the unknown
2000 Standout
Medical Treatment of Advanced Testicular Cancer
2008
Prognostic significance of Ki-67 reactivity in soft tissue sarcomas
1989
Brachytherapy for Locally Recurrent Soft-Tissue Sarcoma
2002
The Clavien-Dindo Classification of Surgical Complications
2009 Standout
Immunophenotype, proliferation, DNA ploidy, and biological behavior of gastrointestinal stromal tumors: A multivariate clinicopathologic study
1998
Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial
2012 Standout
Human health risk assessment of antibiotic resistance associated with antibiotic residues in the environment: A review
2018 Standout
Conformity to clinical practice guidelines, multidisciplinary management and outcome of treatment for soft tissue sarcomas
2004
Prognostic factors in soft tissue sarcomas. A multivariate analysis of 109 cases
1989
Primary Retroperitoneal Sarcomas: A Multivariate Analysis of Surgical Factors Associated With Local Control
2008
Tumour stem cells and drug resistance
2005 Standout
How To Build and Interpret a Nomogram for Cancer Prognosis
2008 Standout
Prognostic Factors for the Outcome of Chemotherapy in Advanced Soft Tissue Sarcoma: An Analysis of 2,185 Patients Treated With Anthracycline-Containing First-Line Regimens—A European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study
1999
Phase II Study of ET-743 in Advanced Soft Tissue Sarcomas: A European Organisation for the Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group Trial
2005 Standout
Anthracyclines suppress pheochromocytoma cell characteristics, including metastasis, through inhibition of the hypoxia signaling pathway
2017 StandoutNobel
Childhood and adolescent cancer statistics, 2014
2014 Standout
Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial
2014 Standout
Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma.
1997
Extracranial Oligometastases: A Subset of Metastases Curable With Stereotactic Radiotherapy
2013
Variable management of soft tissue sarcoma: Regional audit with implications for specialist care
1997
Biology of Gastrointestinal Stromal Tumors
2004 Standout
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. 3. Evaluation of adriamycin conjugates against mouse leukaemia L1210 in vivo
1989
Randomized Phase II Study of Docetaxel Versus Doxorubicin in First- and Second-Line Chemotherapy for Locally Advanced or Metastatic Soft Tissue Sarcomas in Adults: A Study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group
2000
Biodegradable polymers as biomaterials
2007 Standout
The importance of histologic grade in long-term prognosis of breast cancer: a study of 1,010 patients, uniformly treated at the Institut Gustave-Roussy.
1987
Clinicopathologic Re-Evaluation of 100 Malignant Fibrous Histiocytomas: Prognostic Relevance of Subclassification
2001
Adult-Type Soft Tissue Sarcomas in Pediatric-Age Patients: Experience at the Istituto Nazionale Tumori in Milan
2005
Adjuvant Chemotherapy for Soft Tissue Sarcomas
1991
The treatment of soft tissue sarcomas with focus on chemotherapy: A review
1986
Prognostic relevance of a novel proliferation marker, Ki-S11, for soft-tissue sarcoma. A multivariate study.
1997
Origins and Evolution of Antibiotic Resistance
2010 Standout
Long-Term Results of Tumor Necrosis Factor α– and Melphalan-Based Isolated Limb Perfusion in Locally Advanced Extremity Soft Tissue Sarcomas
2011
Irradiation and anti–PD-L1 treatment synergistically promote antitumor immunity in mice
2014 Standout
Safety and efficacy of the multidrug-resistance inhibitor biricodar (VX-710) with concurrent doxorubicin in patients with anthracycline-resistant advanced soft tissue sarcoma.
2002
Variable management of soft tissue sarcoma: Regional audit with implications for specialist care
1997
Works of N.B. Bui being referenced
Refining the optimal chemotherapy regimen for good-risk metastatic nonseminomatous germ-cell tumors: a randomized trial of the Genito-Urinary Group of the French Federation of Cancer Centers (GETUG T93BP)
2007
Prognostic factors in adult patients with locally controlled soft tissue sarcoma. A study of 546 patients from the French Federation of Cancer Centers Sarcoma Group.
1996
Original article: Pharmacokinetics and metabolism of epirubicin administered as i.v. bolus and 48-h infusion in patients with advanced soft-tissue sarcoma
1992
Prognostic variables for the selection of patients with operable soft tissue sarcomas to be considered in adjuvant chemotherapy trials
1992
Soft‐tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system
1984 Standout
Pharmacokinetics of doxorubicin in sarcoma patients
1987
Phase II study with taxotere(RP56976) in advanced soft tissue sarcomas of the adult
1993
[Chemotherapy in advanced malignant melanoma. Results of a controlled trial comparing a combination of dacarbazine (DTIC) and detorubicin with dacarbazine alone].
1982